1. Home
  2. ULY vs JAGX Comparison

ULY vs JAGX Comparison

Compare ULY & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • JAGX
  • Stock Information
  • Founded
  • ULY 2013
  • JAGX 2013
  • Country
  • ULY United States
  • JAGX United States
  • Employees
  • ULY N/A
  • JAGX N/A
  • Industry
  • ULY
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • JAGX Health Care
  • Exchange
  • ULY Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • ULY 6.7M
  • JAGX 11.9M
  • IPO Year
  • ULY N/A
  • JAGX N/A
  • Fundamental
  • Price
  • ULY $0.48
  • JAGX $1.07
  • Analyst Decision
  • ULY Strong Buy
  • JAGX
  • Analyst Count
  • ULY 1
  • JAGX 0
  • Target Price
  • ULY $1.50
  • JAGX N/A
  • AVG Volume (30 Days)
  • ULY 346.1K
  • JAGX 604.8K
  • Earning Date
  • ULY 11-12-2024
  • JAGX 11-13-2024
  • Dividend Yield
  • ULY N/A
  • JAGX N/A
  • EPS Growth
  • ULY N/A
  • JAGX N/A
  • EPS
  • ULY 7.18
  • JAGX N/A
  • Revenue
  • ULY $155,926,000.00
  • JAGX $10,480,000.00
  • Revenue This Year
  • ULY N/A
  • JAGX $18.18
  • Revenue Next Year
  • ULY $20.40
  • JAGX $40.06
  • P/E Ratio
  • ULY $0.07
  • JAGX N/A
  • Revenue Growth
  • ULY N/A
  • JAGX N/A
  • 52 Week Low
  • ULY $0.41
  • JAGX $0.84
  • 52 Week High
  • ULY $3.45
  • JAGX $21.60
  • Technical
  • Relative Strength Index (RSI)
  • ULY 38.34
  • JAGX 50.60
  • Support Level
  • ULY $0.44
  • JAGX $0.85
  • Resistance Level
  • ULY $0.53
  • JAGX $1.10
  • Average True Range (ATR)
  • ULY 0.06
  • JAGX 0.11
  • MACD
  • ULY -0.00
  • JAGX 0.01
  • Stochastic Oscillator
  • ULY 20.87
  • JAGX 37.22

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: